Third, as acknowledged below in limitations we are unable to determine if the origin of mutations in cfDNA in our study is from tumor or germline and this may also have increased the incidence of BRCA1 alterations as compared to historical tissue somatic testing results. Here, BRCA1 is linked to neoplasm.